Form 8-K - Current report:
SEC Accession No. 0001641172-25-026054
Filing Date
2025-08-29
Accepted
2025-08-29 17:16:00
Documents
27
Period of Report
2025-08-29
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K form8-k.htm   iXBRL 8-K 37972
2 EX-99.1 ex99-1.htm EX-99.1 10241
3 GRAPHIC ex99-1_001.jpg GRAPHIC 340985
4 GRAPHIC ex99-1_002.jpg GRAPHIC 362123
5 GRAPHIC ex99-1_003.jpg GRAPHIC 362488
6 GRAPHIC ex99-1_004.jpg GRAPHIC 302124
7 GRAPHIC ex99-1_005.jpg GRAPHIC 320143
8 GRAPHIC ex99-1_006.jpg GRAPHIC 338411
9 GRAPHIC ex99-1_007.jpg GRAPHIC 400270
10 GRAPHIC ex99-1_008.jpg GRAPHIC 219460
11 GRAPHIC ex99-1_009.jpg GRAPHIC 304462
12 GRAPHIC ex99-1_010.jpg GRAPHIC 383903
13 GRAPHIC ex99-1_011.jpg GRAPHIC 467998
14 GRAPHIC ex99-1_012.jpg GRAPHIC 283857
15 GRAPHIC ex99-1_013.jpg GRAPHIC 358330
16 GRAPHIC ex99-1_014.jpg GRAPHIC 276778
  Complete submission text file 0001641172-25-026054.txt   6720286

Data Files

Seq Description Document Type Size
17 XBRL SCHEMA FILE envb-20250829.xsd EX-101.SCH 3011
18 XBRL LABEL FILE envb-20250829_lab.xml EX-101.LAB 34239
19 XBRL PRESENTATION FILE envb-20250829_pre.xml EX-101.PRE 22356
29 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3827
Mailing Address 4851 TAMIAMI TRAIL N, SUITE 200 NAPLES FL 34103
Business Address 4851 TAMIAMI TRAIL N, SUITE 200 NAPLES FL 34103 239-302-1707
Enveric Biosciences, Inc. (Filer) CIK: 0000890821 (see all company filings)

EIN.: 954484725 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38286 | Film No.: 251282047
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)